Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Amy Krouse Rosenthal Foundation Research Grant for Early Detection of Ovarian Cancer

    Amy Krouse Rosenthal Foundation Research Grant for Early Detection of Ovarian Cancer supports researchers studying premalignant lesions and biomarkers to detect ovarian cancer and its recurrence.

    Browse similar grants
    Cancer Research Grants 2026New Research Grants This Month
    OverviewSimilar Grants
    OverviewSimilar Grants

    Funder: Foundation for Women's Cancer

    Due Dates: October 7, 2026 (LOI) | December 9, 2026 (Invited full proposals)

    Funding Amounts: $72,500 for one year

    Summary: Supports research on premalignant lesions and biomarkers for early detection of ovarian cancer and its recurrence.

    Key Information: Research must take place at a U.S. institution; applicants need SGO membership, an SGO-member co-investigator, or an SGO sponsor.


    Description

    The Amy Krouse Rosenthal Foundation Research Grant for Early Detection of Ovarian Cancer is offered through the Foundation for Women’s Cancer (FWC), within its 2026–2027 ovarian cancer research grants. It supports early detection and recurrence biomarker development, including research into the biology of premalignant lesions and early ovarian cancer.

    Eligible research includes detecting premalignant lesions such as serous tubal intraepithelial carcinoma (STIC), using approaches such as serum or plasma analysis, uterine lavage, Pap smears, and fallopian tube sampling. The grant also supports biomarker development for detecting ovarian cancer, recurrence, or both. This includes identifying high-risk patients, such as BRCA or PALB2 mutation carriers, and developing early-detection methodologies for these populations.


    Atom

    See the full grant listing

    Sign in to view full eligibility details, sources, similar grants, and AI-powered analysis.